Application 016932
- Type
- NDA
- Sponsor
- SCHERING
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VALISONE | BETAMETHASONE VALERATE | LOTION;TOPICAL | EQ 0.1% BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N016932-001 | VALISONE | BETAMETHASONE VALERATE | EQ 0.1% BASE | LOTION / TOPICAL | Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | N016932-001 | VALISONE | EQ 0.1% BASE | LOTION / TOPICAL | Approved before 1982 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | N016932-001 | VALISONE | EQ 0.1% BASE | LOTION / TOPICAL | Approved before 1982 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N016932-001 | VALISONE | EQ 0.1% BASE | LOTION / TOPICAL | Approved before 1982 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N016932-001 | VALISONE | EQ 0.1% BASE | LOTION / TOPICAL | Approved before 1982 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Betamethasone Valerate | BETAMETHASONE VALERATE | Sun Pharmaceutical Industries, Inc. | 7c96b978-25ff-44c2-bc9c-30ff5e34cffb | 2026-03-23 | Warnings, Adverse reactions | BETAMETHASONE VALERATE |
| Betamethasone Valerate | BETAMETHASONE VALERATE | Preferred Pharmaceuticals Inc. | 50d4763d-5a84-4c45-be06-040c4a527470 | 2026-03-19 | Adverse reactions | BETAMETHASONE VALERATE |
| BETAMETHASONE VALERATE | BETAMETHASONE VALERATE | Preferred Pharmaceuticals, Inc. | bfa4b6f5-3b66-430a-af41-60e3f12982bc | 2026-03-19 | Adverse reactions | BETAMETHASONE VALERATE |
| BETAMETHASONE VALERATE | BETAMETHASONE VALERATE | A-S Medication Solutions | 7281d272-5342-4738-b35c-42570459e9d4 | 2026-02-04 | Adverse reactions | BETAMETHASONE VALERATE |
| Betamethasone Valerate | BETAMETHASONE VALERATE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 0b386ccc-a2d4-4d18-a2d7-e46ff894c674 | 2026-01-28 | Adverse reactions | BETAMETHASONE VALERATE |
| BETAMETHASONE VALERATE | BETAMETHASONE VALERATE | Sun Pharmaceutical Industries, Inc. | 3c85be0f-2731-44f1-a18e-d3852d54846f | 2025-10-02 | Adverse reactions | BETAMETHASONE VALERATE |
| Betamethasone valerate | BETAMETHASONE VALERATE | Alembic Pharmaceuticals Limited | 75d70e76-023c-4a00-954d-79a697bed80f | 2025-09-25 | Adverse reactions | BETAMETHASONE VALERATE |
| Betamethasone Valerate | BETAMETHASONE VALERATE | Preferred Pharmaceuticals Inc. | 985d1f62-4bff-4bf1-b7c7-96cb456ef83d | 2025-02-07 | Adverse reactions | BETAMETHASONE VALERATE |
| BETAMETHASONE VALERATE | BETAMETHASONE VALERATE | A-S Medication Solutions | 02db1402-701c-483c-bfd6-8b7a543ae8ef | 2024-11-11 | Adverse reactions | BETAMETHASONE VALERATE |
| Betamethasone valerate | BETAMETHASONE VALERATE | Alembic Pharmaceuticals Inc. | 3b6fa573-de04-4626-a39a-dca39def6df2 | 2024-08-23 | Adverse reactions | BETAMETHASONE VALERATE |
| Betamethasone Valerate | BETAMETHASONE VALERATE | NuCare Pharmaceuticals,Inc. | a2154b33-0f61-49af-e053-2995a90a1810 | 2024-06-20 | Adverse reactions | BETAMETHASONE VALERATE |
| BETAMETHASONE VALERATE | BETAMETHASONE VALERATE | NuCare Pharmaceuticals,Inc. | 64badc1a-8922-c6e3-e053-2991aa0a8b1c | 2024-06-06 | Adverse reactions | BETAMETHASONE VALERATE |
| Betamethasone Valerate | BETAMETHASONE VALERATE | Padagis Israel Pharmaceuticals Ltd | dc5dfd3e-7762-40c8-880e-c7db80d87749 | 2024-03-31 | Warnings, Adverse reactions | BETAMETHASONE VALERATE |
| Betamethasone Valerate | BETAMETHASONE VALERATE | A-S Medication Solutions | f8711d17-de6a-45e3-8027-b650308207ed | 2023-12-15 | Adverse reactions | BETAMETHASONE VALERATE |
| Betamethasone Valerate | BETAMETHASONE VALERATE | A-S Medication Solutions | d265d143-343f-41ec-9cb4-18d83edb772b | 2023-12-12 | Adverse reactions | BETAMETHASONE VALERATE |
| Betamethasone Valerate | BETAMETHASONE VALERATE | Proficient Rx LP | 036706f1-0a24-4765-9a62-820ad64934be | 2022-06-01 | Adverse reactions | BETAMETHASONE VALERATE |
| Betamethasone Valerate | BETAMETHASONE VALERATE | Cosette Pharmaceuticals, Inc. | 784476d2-5e5c-fdba-a677-8973a777b5ef | 2022-05-05 | Adverse reactions | BETAMETHASONE VALERATE |
| Betamethasone Valerate | BETAMETHASONE VALERATE | Proficient Rx LP | 2a64b65b-8a49-45ea-9464-2269751c075c | 2021-04-01 | Adverse reactions | BETAMETHASONE VALERATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.